This will be a very unique conference that will allow public and private payers and oncology healthcare providers to come together to present and discuss their views regarding their current and future unmet needs in oncology indications . This discussion will help bring fresh insight & discussion amongst key stakeholders to prevent the wasted development of “me-too” drugs in the coming years, and to encourage investment into therapies for indications that achieve budget-effective medical "innovation" and improve patient access to high-value medications. Request agenda:

www.nextlevelpharma.com | Erika Vavrovicova +421 232660382 | This e-mail address is being protected from spambots. You need JavaScript enabled to view it